Ozempic cuts risk of death from kidney disease, major study finds - The Washington Post

Novo Nordisk will seek FDA approval to dramatically expand the number of patients eligible for the shots.

By: The Washington Post

May 26 2024
0
0 Views

The active compound in the best-selling drug Ozempic markedly lowers the risk of complications from chronic kidney disease, according to a multiyear study published Friday a finding that could dramat… [+631 chars]

Undercooked bear meat to blame for infecting family with rare roundworm parasite: CDC - Fox News

Walmart, Capital One end exclusive credit card agreement - USA TODAY

Why Deckers Outdoor Stock Hit a New All-Time High Today Above $1,000 Per Share - Yahoo Finance

Frontier Airlines says its facing 'widespread abuse' of wheelchair service - Fox Business

Guardant Health Soars Higher. Blood Screen for Cancer Could Be Moving Toward FDA Approval. - Barron's

Nvidia's 10-for-1 stock split confirms 'big tech is going bite-sized' to lure retail investors, BofA says - Fortune

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network

all our websites